These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31144498)

  • 21. A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness.
    Lai J; Moya L; An J; Hoffman A; Srinivasan S; Panchadsaram J; Walpole C; Perry-Keene JL; Chambers S; ; Lehman ML; Nelson CC; Clements JA; Batra J
    Sci Rep; 2017 Dec; 7(1):16862. PubMed ID: 29203868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers.
    Rostami S; Nabi M; Naghavi P; Mohammadzadeh N; Khalili A
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
    Neveu B; Jain P; Têtu B; Wu L; Fradet Y; Pouliot F
    Oncotarget; 2016 Jan; 7(2):1300-10. PubMed ID: 26594800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors.
    Crulhas BP; Basso CR; Castro GR; Pedrosa VA
    Curr Med Chem; 2022; 29(37):5895-5902. PubMed ID: 35674300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA.
    Drayton RM; Rehman I; Clarke R; Zhao Z; Pang K; Miah S; Stoehr R; Hartmann A; Blizard S; Lavin M; Bryant HE; Martens-Uzunova ES; Jenster G; Hamdy FC; Gardiner RA; Catto JW
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):268-75. PubMed ID: 25392181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy.
    Nygård Y; Haukaas SA; Halvorsen OJ; Gravdal K; Frugård J; Akslen LA; Beisland C
    BMC Urol; 2016 Jul; 16(1):39. PubMed ID: 27391229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer.
    Kaufmann S; Bedke J; Gatidis S; Hennenlotter J; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Kruck S
    World J Urol; 2016 Apr; 34(4):509-15. PubMed ID: 26267808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.
    Schalken JA; Hessels D; Verhaegh G
    Urology; 2003 Nov; 62(5 Suppl 1):34-43. PubMed ID: 14607216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prostate cancer gene 3 (PCA3) scores are associated with elevated Prostate Imaging Reporting and Data System (PI-RADS) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software-based targeted prostate biopsy after a previous negative standard biopsy.
    De Luca S; Passera R; Cattaneo G; Manfredi M; Mele F; Fiori C; Bollito E; Cirillo S; Porpiglia F
    BJU Int; 2016 Nov; 118(5):723-730. PubMed ID: 27112799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
    Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
    Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progensa™ PCA3 test for prostate cancer.
    Durand X; Moutereau S; Xylinas E; de la Taille A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):137-44. PubMed ID: 21405964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal Ti
    Zhang Q; Wang F; Zhang H; Zhang Y; Liu M; Liu Y
    Anal Chem; 2018 Nov; 90(21):12737-12744. PubMed ID: 30350604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
    Lin C; Wang J; Wang Y; Zhu P; Liu X; Li N; Liu J; Yu L; Wang W
    Anticancer Res; 2017 Aug; 37(8):4303-4310. PubMed ID: 28739722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCA3: from basic molecular science to the clinical lab.
    Day JR; Jost M; Reynolds MA; Groskopf J; Rittenhouse H
    Cancer Lett; 2011 Feb; 301(1):1-6. PubMed ID: 21093148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer.
    Fontenete S; Nogueira A; Pina F; Lobo F; Fraga A; Calais da Silva F; Medeiros R
    Genet Test Mol Biomarkers; 2012 May; 16(5):418-22. PubMed ID: 22288776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.
    Huang J; Reilly KH; Zhang HZ; Wang HB
    BMC Urol; 2015 Dec; 15():118. PubMed ID: 26628213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.